SMTI
Sanara MedTech Inc.NASDAQHealthcare$17.24-0.06%ClosedMarket Cap: $158.0M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
25.00
P/S
1.53
EV/EBITDA
16.02
DCF Value
$62.15
FCF Yield
1.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
90.1%
Operating Margin
8.9%
Net Margin
-36.4%
ROE
-178.6%
ROA
-51.5%
ROIC
16.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $27.5M | 83.5% | $8.3M | $-1.6M | $-0.20 | — |
| FY 2025 | $103.1M | 90.1% | $9.1M | $-37.6M | $-4.36 | — |
| Q3 2025 | $26.3M | 92.9% | $3.0M | $-30.4M | $-3.52 | — |
| Q2 2025 | $25.8M | 92.5% | $-31.3K | $-2.0M | $-0.23 | — |
| Q1 2025 | $23.4M | 92.2% | $-2.1M | $-3.5M | $-0.41 | — |
| Q4 2024 | $26.3M | 91.4% | $-374.9K | $-1.5M | $-0.18 | — |
| FY 2024 | $86.7M | 90.6% | $-6.7M | $-9.7M | $-1.14 | — |
| Q3 2024 | $21.7M | 90.8% | $-1.9M | $-2.9M | $-0.34 | — |
| Q2 2024 | $20.2M | 90.0% | $-2.9M | $-3.5M | $-0.41 | — |
| Q1 2024 | $18.5M | 89.8% | $-1.5M | $-1.8M | $-0.21 | — |
| Q4 2023 | $17.7M | 89.9% | $-226.0K | $-237.2K | $-0.03 | — |
| FY 2023 | $65.0M | 87.9% | $-4.2M | $-4.3M | $-0.52 | — |